BCL2 - BCL2 apoptosis regulator Gene
Species: Bos taurus
Gene Type: protein coding
Gene ID: 281020
About BCL2
Primary_assembly 24: 61,396,513-61,588,241 reverse strand.ARS-UCD1.2:CM008191.2
This gene has 1 transcript (splice variant), 230 orthologues and 10 paralogues.
BCL2 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001166486.1 | NP_001159958.1 | apoptosis regulator Bcl-2 |
BCL2 Protein Structure
bcl-2
bcl-2: TIGR00865 (0 - 228)
- 0
- 100
- 200
- 229 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
apoptosis regulator Bcl-2 |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(19)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-15531 | Venetoclax | 99.95% | Yes | |
| HY-10201 | Sorafenib | 99.85% | Yes | |
| HY-B0011 | Docetaxel | 99.94% | Unkown | |
| HY-B0318 | Metronidazole | 99.98% | Yes | |
| HY-10201A | Sorafenib tosylate | 99.98% | Yes | |
| HY-148026 | Sonrotoclax | Inhibitor | 99.61% | Unkown |
| HY-13407 | Gossypol | Antagonist | 99.67% | Yes |
| HY-B0011A | Docetaxel Trihydrate | 99.92% | Unkown | |
| HY-B0766 | Bicyclol | 99.91% | Unkown | |
| HY-17510 | Gossypol (acetic acid) | Inhibitor | 99.75% | Yes |
| HY-B1060 | Methylprednisolone succinate sodium | Agonist | 98.82% | Yes |
| HY-B1065 | Aceglutamide | 98.0% | Unkown | |
| HY-15531R | Venetoclax (Standard) | 99.90% | Unkown | |
| HY-B1900 | Methylprednisolone succinate | 99.67% | Yes | |
| HY-W040128 | Kanamycins sulfate | 99.22% | Unkown | |
| HY-B0011R | Docetaxel (Standard) | 99.92% | Unkown | |
| HY-B0877 | Halcinonide | 98.29% | Unkown | |
| HY-B0420A | Moroxydine hydrochloride | Inhibitor | 99.36% | Unkown |
| HY-B0318A | Metronidazole hydrochloride | 98.44% | Yes |
Clinical Phase
Bioactive Molecules
(32)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-105930 | Lobaplatin | 98.0% | Phase 4 | |
| HY-10087 | Navitoclax | Inhibitor | 99.97% | Phase 3 |
| HY-N1423 | Glycocholic acid | 99.90% | Phase 3 | |
| HY-10969 | Obatoclax Mesylate | 99.85% | Phase 3 | |
| HY-118874A | Oblimersen sodium | Inhibitor | 98.09% | Phase 3 |
| HY-10969A | Obatoclax | ≥99.0% | Phase 3 | |
| HY-N0867 | 13-Oxyingenol-13-dodecanoate | 99.37% | Phase 3 | |
| HY-118874 | Oblimersen | / | Phase 3 | |
| HY-130604 | DT2216 | 99.97% | Phase 2 | |
| HY-50868 | Bafetinib | 99.18% | Phase 2 | |
| HY-129179 | Lisaftoclax | Inhibitor | 99.78% | Phase 2 |
| HY-126741 | Azadirachtin | 99.06% | Phase 2 | |
| HY-147081A | AS 1411 sodium | Inhibitor | 99.52% | Phase 2 |
| HY-109185 | Pelcitoclax | 99.70% | Phase 2 | |
| HY-N0068 | Solasodine | 99.97% | Phase 2 | |
| HY-15464 | (R)-(-)-Gossypol | 99.37% | Phase 2 | |
| HY-15464D | (S)-Gossypol (acetic acid) | Inhibitor | 98.46% | Phase 2 |
| HY-15464A | (R)-(-)-Gossypol acetic acid | 98.93% | Phase 2 | |
| HY-138697 | S65487 | 99.91% | Phase 2 | |
| HY-138697A | S65487 sulfate | 99.35% | Phase 2 | |
| HY-138697B | S65487 hydrochloride | 98.54% | Phase 2 | |
| HY-153495 | Prexigebersen | / | Phase 2 | |
| HY-168739 | Topoisomerase I inhibitor 17 | / | Phase 2 | |
| HY-177618 | Beclanorsen | Inhibitor | / | Phase 2 |
| HY-177618A | Beclanorsen sodium | Inhibitor | / | Phase 2 |
| HY-N0168 | Hesperetin | Modulator | 99.12% | Phase 1 |
| HY-117288 | S55746 | Inhibitor | 99.91% | Phase 1 |
| HY-155163 | APG-2449 | Inhibitor | 98.93% | Phase 1 |
| HY-109184 | Murizatoclax | Inhibitor | 98.84% | Phase 1 |
| HY-117288A | S55746 hydrochloride | Inhibitor | 98.83% | Phase 1 |
| HY-168983 | Lonitoclax | Inhibitor | / | Phase 1 |
| HY-165550 | Sphingosine | / | Phase 1 |
Bioactive MoleculesInhibitory Antibodies
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-P991883 | Metuzumab | / | Phase 4 |
Pre-clinical Phase
Bioactive Molecules
(467)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-50907 | ABT-737 | 99.64% | Unkown | |
| HY-N0171A | Beta-Sitosterol (purity>98%) | 99.74% | Unkown | |
| HY-N0292 | Oleuropein | 99.97% | Unkown | |
| HY-107738 | Guggulsterone | 99.83% | Unkown | |
| HY-N0171 | Beta-Sitosterol (purity>80%) | Inducer | ≥98.0% | Unkown |
| HY-N2342 | Procyanidin C1 | Inducer | 99.54% | Unkown |
| HY-N0087 | Gambogic Acid | 98.34% | Unkown | |
| HY-W250111 | Carboxymethyl chitosan | 90% | Unkown | |
| HY-126477 | NNK | 99.97% | Unkown | |
| HY-N0361 | Dihydrocapsaicin | 99.93% | Unkown | |
| HY-N0674 | Dehydrocorydaline | 99.77% | Unkown | |
| HY-18628 | UMI-77 | Inhibitor | 99.66% | Unkown |
| HY-103243 | TCPOBOP | Inhibitor | 99.70% | Unkown |
| HY-112416 | AZD4320 | Inhibitor | 99.66% | Unkown |
| HY-147081 | AS 1411 | Inhibitor | 99.52% | Unkown |
| HY-W250122 | Glutamic acid sodium salt | 99.92% | Unkown | |
| HY-174228 | I3IN-002 | 99.35% | Unkown | |
| HY-N0763 | Angelicin | 99.98% | Unkown | |
| HY-N2897 | Dihydrokaempferol | 99.92% | Unkown | |
| HY-155956 | GM-90257 | 99.90% | Unkown | |
| HY-N3584 | Paris saponin VII | 99.84% | Unkown | |
| HY-128483 | Fusaric acid | 99.94% | Unkown | |
| HY-15531S | Venetoclax-d8 | 99.76% | Unkown | |
| HY-113438 | 15(S)-HPETE | 97.32% | Unkown | |
| HY-N0171R | Beta-Sitosterol (Standard) | Inducer | 98.18% | Unkown |
| HY-124284 | Hexamethylene bisacetamide | 99.56% | Unkown | |
| HY-N1255 | Scoulerine | 99.99% | Unkown | |
| HY-138832 | BM-1244 | 99.83% | Unkown | |
| HY-N0559 | Kirenol | 99.82% | Unkown | |
| HY-N1423A | Glycocholic acid sodium | 97.0% | Unkown | |
| HY-159059 | Ganoderma Lucidum/Reishi Extract | 41.20% | Unkown | |
| HY-N1423S | Glycocholic acid-d4 | 99.92% | Unkown | |
| HY-N12060 | Ginkgo biloba extract | Inhibitor | / | Unkown |
| HY-12875 | BQU57 | Inhibitor | 98.47% | Unkown |
| HY-125876 | PROTAC Bcl2 degrader-1 | Inhibitor | 99.80% | Unkown |
| HY-N0657 | Pinoresinol Diglucoside | 99.84% | Unkown | |
| HY-N1440 | Koumine | Activator | 99.97% | Unkown |
| HY-126437 | Poly-L-lysine hydrobromide (MW 30000-70000) | / | Unkown | |
| HY-N0674A | Dehydrocorydaline chloride | 99.75% | Unkown | |
| HY-125877 | PROTAC Mcl1 degrader-1 | Inhibitor | 98.13% | Unkown |
| HY-B1839 | Fluazinam | 99.51% | Unkown | |
| HY-P1527 | Bim BH3 | 99.74% | Unkown | |
| HY-101259 | BMS-195614 | 99.5% | Unkown | |
| HY-N7675 | Flavanomarein | Inhibitor | 99.92% | Unkown |
| HY-Y0315 | Hexane-2,5-dione | 99.96% | Unkown | |
| HY-12020 | TW-37 | Inhibitor | 99.50% | Unkown |
| HY-N6850 | Calenduloside E | 99.07% | Unkown | |
| HY-P2970 | Stem bromelain | / | Unkown | |
| HY-33350 | Clofilium tosylate | 99.60% | Unkown | |
| HY-N0392 | Polygalasaponin F | 99.85% | Unkown | |
| HY-P1889 | Bim BH3, Peptide IV | 99.24% | Unkown | |
| HY-153803 | GBD-9 | Degrader | 99.91% | Unkown |
| HY-N2067 | Vanillyl alcohol | Inhibitor | 99.68% | Unkown |
| HY-N6005 | Methyl caffeate | 99.89% | Unkown | |
| HY-P1380A | Difopein TFA | 95.35% | Unkown | |
| HY-15191 | Sabutoclax | Inhibitor | 99.80% | Unkown |
| HY-177306 | Opitor-0 | Inhibitor | 98.02% | Unkown |
| HY-N0863 | Methyl protodioscin | 99.67% | Unkown | |
| HY-N2132 | Flavokawain B | 99.99% | Unkown | |
| HY-N3009 | Secoxyloganin | 99.33% | Unkown | |
| HY-N6082 | Rhein 8-O-β-D-Glucopyranoside | Inhibitor | 99.81% | Unkown |
| HY-100383 | BH3I-1 | 98.0% | Unkown | |
| HY-101310 | SYM 2081 | 98.0% | Unkown | |
| HY-11095 | NPS 2390 | 99.90% | Unkown | |
| HY-129700 | MCL-1/BCL-2-IN-2 | Inhibitor | 99.05% | Unkown |
| HY-N3031 | Grosvenorine | 99.64% | Unkown | |
| HY-N3405 | Lariciresinol | 99.46% | Unkown | |
| HY-133557 | XZ739 | 99.08% | Unkown | |
| HY-12011 | HA14-1 | Inhibitor | 98.0% | Unkown |
| HY-157176 | BAX-IN-1 | Inhibitor | 98.05% | Unkown |
| HY-169266 | BRD-K56819078 | Inhibitor | 99.93% | Unkown |
| HY-N0566 | 23-Hydroxybetulinic acid | 99.44% | Unkown | |
| HY-N0757 | 8-O-Acetylharpagide | 99.75% | Unkown | |
| HY-N1983 | Caudatin | Inducer | 99.95% | Unkown |
| HY-139309 | PROTAC Bcl-xL degrader-2 | Inhibitor | 98.23% | Unkown |
| HY-120882 | BM-1197 | Inhibitor | 99.48% | Unkown |
| HY-101195 | DL-erythro-Dihydrosphingosine | Inhibitor | 98.0% | Unkown |
| HY-107835 | Flumethrin | 99.29% | Unkown | |
| HY-113471A | (S)-(-)-Perillic acid | 99.9% | Unkown | |
| HY-172209 | PPIA-IN-1 | 96.90% | Unkown | |
| HY-N0307 | Ciwujianoside B | Inhibitor | 99.68% | Unkown |
| HY-N0674B | Dehydrocorydaline (hydroxyl) | 99.52% | Unkown | |
| HY-W013105 | Sodium glycocholate hydrate, 98% | 99.91% | Unkown | |
| HY-129681 | MCL-1/BCL-2-IN-1 | Inhibitor | 98.65% | Unkown |
| HY-162858 | BRD-810 | 98.00% | Unkown | |
| HY-B0011S | Docetaxel-d9 | 98.65% | Unkown | |
| HY-101997 | BEPP hydrochloride | 99.62% | Unkown | |
| HY-156278 | FB49 | Inhibitor | 99.76% | Unkown |
| HY-16014 | A-385358 | Inhibitor | 95.10% | Unkown |
| HY-161410 | WH244 | Degrader | 99.82% | Unkown |
| HY-N2135 | Puerarin 6''-O-Xyloside | 99.81% | Unkown | |
| HY-N2416 | Taccalonolide A | 99.29% | Unkown | |
| HY-N7930 | Crenulatin | 99.85% | Unkown | |
| HY-NP192 | Sericin | 0% | Unkown | |
| HY-119931 | 2-Hydroxychalcone | 98.54% | Unkown | |
| HY-172798 | XZ338 | Degrader | 98.17% | Unkown |
| HY-179528 | DIM-3,5-Cl2 | 99.18% | Unkown | |
| HY-N6576 | Hellebrigenin | 99.69% | Unkown | |
| HY-P2343 | BH3 hydrochloride | Activator | 98.03% | Unkown |
| HY-W674241 | 4-Ethylphenyl sulfate | Inducer | / | Unkown |
| HY-N0853A | Alisol A 24-acetate | 98.0% | Unkown | |
| HY-P10336 | Serpinin | Agonist | 98.74% | Unkown |
| HY-142209 | ABBV-167 | Inhibitor | 98.10% | Unkown |
| HY-132307 | Mcl-1 inhibitor 6 | 98.77% | Unkown | |
| HY-16967 | MM41 | 98.89% | Unkown | |
| HY-101083 | BDA-366 | Antagonist | 98.42% | Unkown |
| HY-147929 | Apoptotic agent-3 | 98.19% | Unkown | |
| HY-169265 | BRD-K20733377 | Inhibitor | 99.50% | Unkown |
| HY-167881 | MLS-0053105 | Inhibitor | 98.89% | Unkown |
| HY-10087S | Navitoclax-d8 | Inhibitor | 99.71% | Unkown |
| HY-111329 | JGB1741 | 99.37% | Unkown | |
| HY-129702 | MCL-1/BCL-2-IN-4 | Inhibitor | 99.95% | Unkown |
| HY-147785 | Pim-1 kinase inhibitor 2 | 99.91% | Unkown | |
| HY-156096 | HDAC3-IN-2 | / | Unkown | |
| HY-161100 | BDM19 | Inducer | 99.38% | Unkown |
| HY-B1752 | Quinpirole | 98.95% | Unkown | |
| HY-N0320 | Salvianolic acid D | 95.15% | Unkown | |
| HY-N1157 | Thevetiaflavone | 99.83% | Unkown | |
| HY-N1423B | Glycocholic acid hydrate | 99.85% | Unkown | |
| HY-N7905 | Myricetin 3'-glucoside | Inhibitor | 99.98% | Unkown |
| HY-N0882 | Desacetylcinobufotalin | 99.41% | Unkown | |
| HY-N1414A | 3′,6-Disinapoylsucrose | Inhibitor | 98.88% | Unkown |
| HY-N1930 | (-)-Hinesol | Inducer | 98.7% | Unkown |
| HY-Y0315S | 2,5-Hexanedione-d10 | 98.55% | Unkown | |
| HY-111837 | BI1071 | / | Unkown | |
| HY-119979 | Cardanol monoene | Inducer | 98.02% | Unkown |
| HY-135273 | A-1211212 | 98.43% | Unkown | |
| HY-161254 | ATPase-IN-3 | 99.89% | Unkown | |
| HY-169925 | BM-962 | Inhibitor | 99.10% | Unkown |
| HY-B1900R | Methylprednisolone succinate (Standard) | 98.90% | Unkown | |
| HY-N4238 | Dehydrocorydaline nitrate | 99.89% | Unkown | |
| HY-109617 | 4-(4-Fluorophenyl)benzoic acid | 99.01% | Unkown | |
| HY-N13250 | Hawthorn Extract | / | Unkown | |
| HY-N4308 | Hexamethylquercetagetin | Inhibitor | 98.0% | Unkown |
| HY-RS01415 | BCL2 Human Pre-designed siRNA Set A | / | Unkown | |
| HY-156620 | Lacutoclax | Inhibitor | / | Unkown |
| HY-175342 | FCN-338 | Inhibitor | 99.33% | Unkown |
| HY-19551 | Apogossypolone | 98.58% | Unkown | |
| HY-119833 | Rubone | Modulator | 99.1% | Unkown |
| HY-129179B | (Rac)-Lisaftoclax | Inhibitor | 98.22% | Unkown |
| HY-129488 | FPFS-1169 hydrochloride | Agonist | 99.83% | Unkown |
| HY-129701 | MCL-1/BCL-2-IN-3 | Inhibitor | 98.93% | Unkown |
| HY-133772 | Venetoclax N-oxide | 99.66% | Unkown | |
| HY-13408 | (+)-Apogossypol | Inhibitor | / | Unkown |
| HY-160108 | Bcl-2-IN-17 | Inhibitor | / | Unkown |
| HY-160921 | Capeserod | Agonist | 98.66% | Unkown |
| HY-161276 | BFC1108 | Inducer | 98.11% | Unkown |
| HY-161659 | Apoptosis inducer 19 | 98.31% | Unkown | |
| HY-170820 | XYD049 | Inhibitor | 99.46% | Unkown |
| HY-174873 | AF151 | 98.87% | Unkown | |
| HY-177102 | Mesutoclax | Inhibitor | 98.69% | Unkown |
| HY-N10144 | Shinpterocarpin | Inhibitor | / | Unkown |
| HY-N1423S1 | Glycocholic acid-d5 | 99.9% | Unkown | |
| HY-N1983R | Caudatin (Standard) | Inducer | 99.31% | Unkown |
| HY-N2199 | Sotetsuflavone | 96.75% | Unkown | |
| HY-N6674 | Diazepinomicin | 98.04% | Unkown | |
| HY-N6690 | Destruxin B | 99.86% | Unkown | |
| HY-P1733 | BMf-BH3 | / | Unkown | |
| HY-P5325A | Bid BH3 (80-99) acetate | 98.13% | Unkown | |
| HY-RS01431 | BCL2L13 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W073128 | Perfluorotetradecanoic acid | 98.0% | Unkown | |
| HY-W674241A | 4-Ethylphenyl sulfate sodium | Inducer | / | Unkown |
| HY-15191B | (S)-Sabutoclax | Inhibitor | 98.03% | Unkown |
| HY-B1559 | Allethrin | Inducer | 98.04% | Unkown |
| HY-N1218 | Stellasterol | Inhibitor | / | Unkown |
| HY-N16483 | Procyanidin B2-3'-O-gallate | / | Unkown | |
| HY-RS01421 | BCL2L1 Human Pre-designed siRNA Set A | / | Unkown | |
| HY-W075770 | Nickel(II) oxide | ≥99.0% | Unkown | |
| HY-10087A1 | Navitoclax dihydrochloride | / | Unkown | |
| HY-114310 | VDR agonist 1 | / | Unkown | |
| HY-131247 | Bcl-2-IN-2 | Inhibitor | / | Unkown |
| HY-141876 | PRT543 | / | Unkown | |
| HY-155188 | NWP-0476 | Inhibitor | / | Unkown |
| HY-100762 | Mcl1-IN-11 | Inhibitor | / | Unkown |
| HY-100763 | Mcl1-IN-12 | Inhibitor | / | Unkown |
| HY-146097 | RMS5 | / | Unkown | |
| HY-149918 | Antiproliferative agent-23 | / | Unkown | |
| HY-18106 | BM 957 | Inhibitor | / | Unkown |
| HY-184107 | Bcl-2-IN-25 | Inhibitor | / | Unkown |
| HY-101999 | EM20-25 | / | Unkown | |
| HY-107272 | Chuanbeinone | / | Unkown | |
| HY-107835R | Flumethrin (Standard) | / | Unkown | |
| HY-107835S | Flumethrin-d5 | / | Unkown | |
| HY-115974 | GRPR antagonist-1 | 99.80% | Unkown | |
| HY-116204 | SKLB70326 | / | Unkown | |
| HY-116267 | MHY219 | / | Unkown | |
| HY-117171 | Proquinazid | / | Unkown | |
| HY-119062 | A-800141 | Inhibitor | / | Unkown |
| HY-121934 | BH3I-2' | / | Unkown | |
| HY-123020 | CYD-2-88 | Antagonist | / | Unkown |
| HY-123034 | CDKI-83 | / | Unkown | |
| HY-123244 | YC137 | / | Unkown | |
| HY-123715 | Anticancer agent 255 | / | Unkown | |
| HY-124122 | BPTQ | / | Unkown | |
| HY-124792 | MRLB-223 | / | Unkown | |
| HY-125191 | BRD1991 | Inhibitor | / | Unkown |
| HY-126311 | 4-Hydroxyresveratrol | Inducer | / | Unkown |
| HY-127130 | Spicamycin | / | Unkown | |
| HY-131188 | PROTAC Bcl-xL degrader-1 | Inhibitor | / | Unkown |
| HY-131405 | β-Eleostearic acid | Inhibitor | / | Unkown |
| HY-135275 | BCL-XL-IN-4 | Inhibitor | / | Unkown |
| HY-136778 | INH2BP | / | Unkown | |
| HY-13846 | BM-1074 | / | Unkown | |
| HY-143235 | BRD4 Inhibitor-15 | / | Unkown | |
| HY-143872 | Bcl-2-IN-4 | Inhibitor | / | Unkown |
| HY-143873 | Bcl-2-IN-5 | Inhibitor | / | Unkown |
| HY-144428 | Bcl-2/Mcl-1-IN-2 | Inhibitor | / | Unkown |
| HY-144430 | Bcl-2/Mcl-1-IN-1 | Inhibitor | / | Unkown |
| HY-144431 | Bcl-2/Mcl-1-IN-3 | Inhibitor | / | Unkown |
| HY-144778 | IDO1/TDO-IN-1 | / | Unkown | |
| HY-144791 | Bcl-2-IN-6 | / | Unkown | |
| HY-144792 | Bcl-2-IN-7 | / | Unkown | |
| HY-145288 | Antitumor agent-36 | / | Unkown | |
| HY-145289 | Antitumor agent-37 | / | Unkown | |
| HY-146095 | p53 Activator 2 | / | Unkown | |
| HY-146253 | CDK1/2/4-IN-1 | / | Unkown | |
| HY-146444 | Anticancer agent 56 | / | Unkown | |
| HY-146471 | EGFR-IN-51 | / | Unkown | |
| HY-146472 | EGFR-IN-52 | / | Unkown | |
| HY-146817 | Tubulin polymerization-IN-11 | / | Unkown | |
| HY-147504 | Anticancer agent 63 | / | Unkown | |
| HY-147826 | EGFR-IN-60 | / | Unkown | |
| HY-147906 | Anticancer agent 71 | / | Unkown | |
| HY-147928 | Apoptotic agent-2 | / | Unkown | |
| HY-149009 | Bcl-2-IN-9 | / | Unkown | |
| HY-149024 | VEGFR-2-IN-23 | / | Unkown | |
| HY-149436 | CDK2/Bcl2-IN-1 | Inhibitor | / | Unkown |
| HY-149517 | EGFR/BRAFV600E-IN-2 | / | Unkown | |
| HY-149622 | Bcl-2-IN-12 | Inhibitor | / | Unkown |
| HY-149623 | Bcl-2-IN-13 | Inhibitor | / | Unkown |
| HY-149624 | Bcl-2-IN-14 | Inhibitor | / | Unkown |
| HY-149625 | Bcl-2-IN-15 | Inhibitor | / | Unkown |
| HY-149681 | Beclin1-Bcl-2 interaction inhibitor 1 | Inhibitor | / | Unkown |
| HY-150540 | Bcl-2-IN-10 | / | Unkown | |
| HY-150596 | CT1-3 | / | Unkown | |
| HY-151428 | Antitumor agent-78 | / | Unkown | |
| HY-151429 | Antitumor agent-77 | / | Unkown | |
| HY-151443 | HDAC-IN-47 | Inhibitor | / | Unkown |
| HY-153494 | Rosomidnar | Inhibitor | / | Unkown |
| HY-153494A | Rosomidnar sodium | Inhibitor | / | Unkown |
| HY-153953 | Bcl-2-IN-11 | Inhibitor | / | Unkown |
| HY-155242 | VEGFR-2-IN-36 | / | Unkown | |
| HY-159513 | Bcl-2/Mcl-1-IN-4 | Inhibitor | / | Unkown |
| HY-159668 | DL002 | / | Unkown | |
| HY-159817 | Asaretoclax | Inhibitor | / | Unkown |
| HY-159938 | p38α inhibitor 6 | / | Unkown | |
| HY-161415 | BCL-xL/BCL-2 ligand 1 | / | Unkown | |
| HY-161577 | BFC1103 | / | Unkown | |
| HY-161732 | GQN-B37-E | Inhibitor | / | Unkown |
| HY-161786 | Bcl-2-IN-20 | / | Unkown | |
| HY-162148 | HNPMI | Inhibitor | 99.57% | Unkown |
| HY-162820 | Bcl-2-IN-21 | Inhibitor | / | Unkown |
| HY-162826 | Apoptosis inducer 27 | Inducer | / | Unkown |
| HY-162886 | BSO-07 | Activator | / | Unkown |
| HY-163077 | Anticancer agent 175 | Inducer | / | Unkown |
| HY-163308 | Bcl-2-IN-18 | Inhibitor | / | Unkown |
| HY-163309 | Bcl-2-IN-19 | Inhibitor | / | Unkown |
| HY-163435 | Anticancer agent 201 | / | Unkown | |
| HY-163527 | FGFR-IN-13 | Inhibitor | / | Unkown |
| HY-163764 | Bfl-1-IN-4 | / | Unkown | |
| HY-167237 | Calactin | / | Unkown | |
| HY-167825 | Barakol | / | Unkown | |
| HY-168171 | ERK1/2 inhibitor 11 | / | Unkown | |
| HY-168483 | FTO-IN-13 | / | Unkown | |
| HY-168623 | EGFR-IN-134 | / | Unkown | |
| HY-169083 | Bcl-2-IN-22 | Inhibitor | / | Unkown |
| HY-169096 | DPP-21 | / | Unkown | |
| HY-169124 | Apoptosis inducer 28 | / | Unkown | |
| HY-169267 | BRD-K44839765 | Inhibitor | / | Unkown |
| HY-169412 | MAPK-IN-3 | / | Unkown | |
| HY-169431 | VEGFR-2/AKT-IN-2 | / | Unkown | |
| HY-170366 | VEGFR-2-IN-58 | / | Unkown | |
| HY-170648 | TS-IN-5 | / | Unkown | |
| HY-170689 | CG-3-246 | Inhibitor | / | Unkown |
| HY-170787 | TZEP7 | / | Unkown | |
| HY-170929 | EMT inhibitor-3 | / | Unkown | |
| HY-170932 | EGFR/COX-2-IN-1 | / | Unkown | |
| HY-170946 | WR-S-462 | Inhibitor | / | Unkown |
| HY-172092 | BG11 | Inducer | / | Unkown |
| HY-172393 | TCF4/β-catenin-IN-1 | / | Unkown | |
| HY-172394 | ZSNI-21 | / | Unkown | |
| HY-172551 | anti-TNBC agent-9 | / | Unkown | |
| HY-172623 | EGFR/HER2-IN-17 | / | Unkown | |
| HY-172886 | PI3K-IN-58 | / | Unkown | |
| HY-173365 | VEGFR-2-IN-67 | Inhibitor | / | Unkown |
| HY-174232 | EGFR/CA-IX-IN-1 | / | Unkown | |
| HY-174338 | GPER/Bcl-2-IN-1 | Inhibitor | / | Unkown |
| HY-174403 | c-MYC/BCL2 ligand 1 iodide | / | Unkown | |
| HY-174404 | Topoisomerase II inhibitor 23 | / | Unkown | |
| HY-174419 | TFSeB | / | Unkown | |
| HY-174469 | PROTAC PI3K/110β degrader-2 | / | Unkown | |
| HY-174855 | PI3K/mTOR-IN-17 | / | Unkown | |
| HY-174992 | Apoptosis inducer 39 | Inducer | / | Unkown |
| HY-175010 | STAT3-IN-44 | / | Unkown | |
| HY-175021 | HDAC-IN-91 | / | Unkown | |
| HY-175034 | Topoisomerase I/II-IN-1 | / | Unkown | |
| HY-175037 | DNH28 | / | Unkown | |
| HY-175227 | STAT3/NF-κB-IN-1 | / | Unkown | |
| HY-175317 | Nogo-B-IN-1 | / | Unkown | |
| HY-175332 | Apoptosis inducer 43 | / | Unkown | |
| HY-175397 | Dth | / | Unkown | |
| HY-175588 | EGFR-IN-170 | / | Unkown | |
| HY-175638 | Carbonic anhydrase-IN-35 | / | Unkown | |
| HY-175771 | STAT3-IN-46 | Inhibitor | / | Unkown |
| HY-175815 | Apoptosis inducer 44 | / | Unkown | |
| HY-175841 | Tau Protein Phosphorylation-IN-1 | Inhibitor | / | Unkown |
| HY-175848 | NSC 850745 | / | Unkown | |
| HY-176219 | Bcl-2-IN-23 | / | Unkown | |
| HY-176279 | Hsp90-IN-42 | Inhibitor | / | Unkown |
| HY-17662 | Mol4 | Inhibitor | / | Unkown |
| HY-177076 | Dalvotoclax | Inhibitor | / | Unkown |
| HY-177208 | BW-AQ-113 | / | Unkown | |
| HY-178008 | Mcl-1-IN-16 | / | Unkown | |
| HY-178036 | ZM484 | Inhibitor | / | Unkown |
| HY-178099 | Apoptosis inducer 45 | / | Unkown | |
| HY-178176 | PROTAC CB1R Degrader-1 | / | Unkown | |
| HY-178351 | HDAC6-IN-67 | / | Unkown | |
| HY-178373 | Topoisomerase I-IN-18 | / | Unkown | |
| HY-178380 | HDAC8-IN-14 | / | Unkown | |
| HY-178446 | METTL3-IN-11 | Inhibitor | / | Unkown |
| HY-178910 | Mcl-1-IN-20 | / | Unkown | |
| HY-178911 | TS-IN-8 | / | Unkown | |
| HY-178940 | Apoptosis inducer 49 | / | Unkown | |
| HY-178942 | EGFR/VEGFR2-IN-9 | / | Unkown | |
| HY-179125 | COX-2-IN-59 | / | Unkown | |
| HY-179155 | PI3K/mTOR-IN-19 | / | Unkown | |
| HY-179161 | CDK2-IN-49 | / | Unkown | |
| HY-179439 | Multi-kinase-IN-8 | / | Unkown | |
| HY-179480 | G-quadruplex ligand 4 | / | Unkown | |
| HY-179485 | EGFR/VEGFR2-IN-10 | / | Unkown | |
| HY-179520 | XSJ151 | / | Unkown | |
| HY-179522 | EGFR-IN-186 | / | Unkown | |
| HY-180154 | EGFR/BRAFV600E-IN-6 | / | Unkown | |
| HY-180190 | Tubulin polymerization-IN-85 | / | Unkown | |
| HY-180196 | EGFR-IN-187 | / | Unkown | |
| HY-180242 | EGFR/CDK2-IN-5 | / | Unkown | |
| HY-180245 | STAT3-IN-51 | / | Unkown | |
| HY-180274 | JAK1/2-IN-3 | / | Unkown | |
| HY-180324 | Candidone | / | Unkown | |
| HY-180618 | p53 DUBTAC modulator-1 | / | Unkown | |
| HY-180820 | Dimethyl bisphenolate | / | Unkown | |
| HY-180823 | Topoisomerase II/EGFR-IN-2 | / | Unkown | |
| HY-180848 | Bcl-2-IN-24 | / | Unkown | |
| HY-181015 | α-D-Manp(3→1)-α-D-Manp(2→1)-α-D-Glu | / | Unkown | |
| HY-181018 | Topo I/DDX5-IN-1 | / | Unkown | |
| HY-181060 | Apoptosis inducer 56 | / | Unkown | |
| HY-181061 | COX/5-LO-IN-2 | / | Unkown | |
| HY-181087 | Anticancer agent 296 | / | Unkown | |
| HY-181174 | Antioxidant agent-22 | / | Unkown | |
| HY-181413 | PROTAC EZH2 Degrader-44 | / | Unkown | |
| HY-181477 | ERK5-IN-7 | / | Unkown | |
| HY-181505 | BRD4-IN-12 | / | Unkown | |
| HY-181673 | ICD inducer-2 | / | Unkown | |
| HY-181723 | Anticancer agent 304 | / | Unkown | |
| HY-181725 | Topoisomerase I-IN-20 | / | Unkown | |
| HY-181746 | Bcl-2/Mcl-1-IN-5 | / | Unkown | |
| HY-181769 | Anticancer agent 306 | / | Unkown | |
| HY-181795 | CSN5-IN-3 | / | Unkown | |
| HY-182060 | PDE4B/D-IN-5 | / | Unkown | |
| HY-182069 | CDK9-IN-47 | / | Unkown | |
| HY-182243 | HK2-IN-4 | / | Unkown | |
| HY-182284 | Anticancer agent 310 | / | Unkown | |
| HY-182360 | Cytisine-platinum(IV) prodrug-1 | / | Unkown | |
| HY-182469 | FuBIG | / | Unkown | |
| HY-182706 | NSC 373981 | Inhibitor | / | Unkown |
| HY-182745 | VEGFR-2-IN-85 | / | Unkown | |
| HY-182759 | MN33-47 | / | Unkown | |
| HY-182760 | MN33-63 | / | Unkown | |
| HY-182763 | EGFR/BRAFV600E-IN-7 | / | Unkown | |
| HY-182986 | LS-Q2 | / | Unkown | |
| HY-183069 | FKL-137 | / | Unkown | |
| HY-183327 | PI3K/mTOR-IN-22 | Inhibitor | / | Unkown |
| HY-183330 | Topo I/II-IN-3 | / | Unkown | |
| HY-183355 | KRAS G12D-IN-37 | / | Unkown | |
| HY-183369 | VEGFR/PD-L1-IN-1 | / | Unkown | |
| HY-183791A | Ferroptosis/apoptosis inducer-5 | / | Unkown | |
| HY-184116 | A2AR/EGFR-IN-1 | / | Unkown | |
| HY-184145 | AKT1-IN-13 | / | Unkown | |
| HY-184302 | Apoptosis inducer 62 | / | Unkown | |
| HY-184443 | Bcl-2-IN-26 | / | Unkown | |
| HY-185559 | Mito-fisetin mF7 | / | Unkown | |
| HY-18628S | UMI-77-d4 | Inhibitor | / | Unkown |
| HY-50907S | ABT-737-d8 | 99.11% | Unkown | |
| HY-B0011AS | Docetaxel-d5 trihydrate | / | Unkown | |
| HY-N0307R | Ciwujianoside B (Standard) | Inhibitor | / | Unkown |
| HY-N0361S | Dihydrocapsaicin-d3 | / | Unkown | |
| HY-N0392R | Polygalasaponin F (Standard) | Inhibitor | / | Unkown |
| HY-N0559R | Kirenol (Standard) | / | Unkown | |
| HY-N0757R | 8-O-Acetylharpagide (Standard) | / | Unkown | |
| HY-N10091 | 2,3-Dihydro-3α-methoxynimbolide | / | Unkown | |
| HY-N10342 | Cajanol | / | Unkown | |
| HY-N1255A | Scoulerine hydrochloride | / | Unkown | |
| HY-N13338 | Avicin D | / | Unkown | |
| HY-N15449 | Vicanicin | / | Unkown | |
| HY-N16771 | Clausenidin | / | Unkown | |
| HY-N16929 | Gymnoside II | / | Unkown | |
| HY-N17440 | 2-Methoxyjuglone | / | Unkown | |
| HY-N17617 | S-Petasin | / | Unkown | |
| HY-N17816 | Tambulin | / | Unkown | |
| HY-N20627 | Withametelin B | / | Unkown | |
| HY-N2741 | Vitexin B-1 | Inhibitor | / | Unkown |
| HY-N3828 | epi-Eriocalyxin A | / | Unkown | |
| HY-N6799 | Neosolaniol | 99.72% | Unkown | |
| HY-N7917 | Tenacigenoside A | / | Unkown | |
| HY-N9778 | Phoyunbene B | / | Unkown | |
| HY-P10057 | cpm-1285 | Inducer | / | Unkown |
| HY-P10058 | cpm-1285m | / | Unkown | |
| HY-P10833 | C-VGB3 | / | Unkown | |
| HY-P11374 | Bid BH3-Gly-r8 | Ligand | / | Unkown |
| HY-P11707 | FS1 peptide | / | Unkown | |
| HY-P1380 | Difopein | / | Unkown | |
| HY-P1889A | Bim BH3, Peptide IV TFA | / | Unkown | |
| HY-P5324 | Bad BH3 (mouse) | / | Unkown | |
| HY-P5325 | Bid BH3 (80-99) | / | Unkown | |
| HY-P5327 | r8 Bid BH3 | / | Unkown | |
| HY-RS01416 | Bcl2 Mouse Pre-designed siRNA Set A | / | Unkown | |
| HY-RS01417 | BCL2 Rat Pre-designed siRNA Set A | / | Unkown | |
| HY-RS01418 | BCL2A1 Human Pre-designed siRNA Set A | / | Unkown | |
| HY-RS01419 | Bcl2a1 Rat Pre-designed siRNA Set A | / | Unkown | |
| HY-RS01420 | Bcl2a1a Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01422 | Bcl2l1 Mouse Pre-designed siRNA Set A | / | Unkown | |
| HY-RS01423 | Bcl2l1 Rat Pre-designed siRNA Set A | / | Unkown | |
| HY-RS01424 | BCL2L10 Human Pre-designed siRNA Set A | / | Unkown | |
| HY-RS01425 | Bcl2l10 Mouse Pre-designed siRNA Set A | / | Unkown | |
| HY-RS01426 | Bcl2l10 Rat Pre-designed siRNA Set A | / | Unkown | |
| HY-RS01427 | BCL2L11 Human Pre-designed siRNA Set A | / | Unkown | |
| HY-RS01428 | Bcl2l11 Mouse Pre-designed siRNA Set A | / | Unkown | |
| HY-RS01429 | Bcl2l11 Rat Pre-designed siRNA Set A | / | Unkown | |
| HY-RS01430 | BCL2L12 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01432 | BCL2L14 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01433 | BCL2L15 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01434 | BCL2L2 Human Pre-designed siRNA Set A | / | Unkown | |
| HY-RS01435 | Bcl2l2 Mouse Pre-designed siRNA Set A | / | Unkown | |
| HY-RS01436 | Bcl2l2 Rat Pre-designed siRNA Set A | / | Unkown | |
| HY-W016937 | Moroxydine | Inhibitor | / | Unkown |
| HY-W713297 | Moroxydine hydrochloride-d8 | Inhibitor | / | Unkown |
| HY-W717425 | SC-60 | / | Unkown | |
| HY-W754548 | Glycocholic acid-13C2,d4 | / | Unkown | |
| HY-101083A | (Rac)-BDA-366 | Inhibitor | / | Unkown |
| HY-115529 | (-)BI97D6 | Inducer | / | Unkown |
| HY-116532 | YCW-E11 | Inhibitor | / | Unkown |
| HY-117136 | AN-7 | / | Unkown | |
| HY-12011A | (Rac)-HA14-1 | Inhibitor | / | Unkown |
| HY-122047 | SW063058 | / | Unkown | |
| HY-136714 | Bcl-2-IN-3 | Inhibitor | / | Unkown |
| HY-15531S1 | Venetoclax-d6 | / | Unkown | |
| HY-164468 | Ch282-5 | Inhibitor | / | Unkown |
| HY-171031 | TFGF-18 | / | Unkown | |
| HY-174635 | Human IL15RA mRNA | / | Unkown | |
| HY-174776 | Human BAX mRNA | / | Unkown | |
| HY-174777 | Human BAK1 mRNA | / | Unkown | |
| HY-181030 | BDE30671203 | / | Unkown | |
| HY-182586 | Decyl gallate | Activator | / | Unkown |
| HY-N15136 | Isomorellinol | Inducer | / | Unkown |
| HY-N15315 | Triptriolide | / | Unkown | |
| HY-N15378 | β-Carotene-15,15'-epoxide | / | Unkown | |
| HY-N15466 | Longan cerebroside II | Inhibitor | / | Unkown |
| HY-N18905 | α-D-Glucosyl hesperidin | / | Unkown | |
| HY-N6082R | Rhein 8-O-β-D-Glucopyranoside (Standard) | / | Unkown | |
| HY-N6799R | Neosolaniol (Standard) | / | Unkown | |
| HY-N6926 | 1,3,5-Tricaffeoylquinic acid | / | Unkown | |
| HY-N8579 | Eugenyl benzoate | ≥90.0% | Unkown | |
| HY-RS21989 | Bcl2l12 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS28507 | Bcl2l12 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W715812 | Bromuconazole | / | Unkown | |
| HY-W747601 | Chlorphoxim | / | Unkown | |
| HY-W751400 | Solasodine hydrochloride | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P990344 | Anti-Bcl-2 Antibody | Inhibitor | / | Unkown |
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Homo sapiens | BCL2 | NCBI | NCBI:596 |
| Mus musculus | BCL2 | NCBI | NCBI:12043 |
| Rattus norvegicus | BCL2 | NCBI | NCBI:24224 |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service